Chemomab completes End-of-Phase 2 Meeting with the FDA for CM-101
Chemomab Therapeutics (CMMB) announced the successful completion of its End-of-Phase 2 Meeting with the FDA and alignment with FDA on the ...
Too Old to Operate4 天
Diagnostic Value of M-Emax in Prostate Diseases Using T-SWE
The following is a summary of “Application of mean maximum Young’s modulus value as a new parameter for differential ...
The Lancet4 天
Non-invasive tests for assessing liver fibrosis and cirrhosis in chronic hepatitis B
Assessment of liver fibrosis and cirrhosis is crucial for the management of patients with chronic hepatitis B. The presence of at least moderate liver fibrosis is an important indication for antiviral ...